✦ LIBER ✦

A phase I clinical and pharmacokinetic study of the dolastatin analogue cemadotin administered as a 5-day continuous intravenous infusion

✍ Scribed by Jeffrey G. Supko; Thomas J. Lynch; Jeffrey W. Clark; Robert Fram; Lee F. Allen; Raja Velagapudi; Donald W. Kufe; Joseph Paul Eder Jr

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I clinical and pharmacokinetic stu

✍ N. Simon Tchekmedyian; Merrill J. Egorin; Brian E. Cohen; Richard S. Kaplan; Eli 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 622 KB

A phase I study of trimetrexate (NSC 352

✍ James F. Bishop; Derek Raghavan; Ian N. Olver; Phillip Reece; Raymond Morris; Mi 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 479 KB

Phase I and pharmacokinetic study of tia

✍ D. Raghavan; J. Bishop; D. Sampson; J. Grygiel; R. Woods; A. Coates; R. Fox 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 484 KB

A phase I pharmacokinetic study of recom

✍ Abraham Mittelman; Carmelo Puccio; Elizabeth Gafney; Nancy Coombe; Brinj Singh; 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 552 KB

Phase I clinical and pharmacology study

✍ Richard L. Schilsky; Mark J. Ratain; Linda Janisch; Nicholas J. Vogelzang; V. So 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 703 KB